Track the 랩지노믹스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 랩지노믹스 has published 71 reports. Market capitalisation: €48.1bn. The latest transaction was filed on 16 June 2026 (Other). Among the most active insiders: 이종훈. The full history is openly available.
71
Insider Decl.
0
Thresholds
·
49 ops.
Buy Volume
·
5 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,279 of 26,282 companies
13.8
score / 100
Value
2
Quality
26
FCF yld-61%
Earn yld-122%
EV/EBITDA·
ROE·
Gross mgn35%
Net mgn-73%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
랩지노믹스 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative diagnostic and treatment solutions.